Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP652023.RADB6JPT_6mBCJiCF8yPVbgcMzXYWt4T4jB5D8PyQ0nmY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP652023.RADB6JPT_6mBCJiCF8yPVbgcMzXYWt4T4jB5D8PyQ0nmY130_assertion type Assertion NP652023.RADB6JPT_6mBCJiCF8yPVbgcMzXYWt4T4jB5D8PyQ0nmY130_head.
- NP652023.RADB6JPT_6mBCJiCF8yPVbgcMzXYWt4T4jB5D8PyQ0nmY130_assertion description "[In addition, the levels of the E7 oncoprotein were at least as high as in cancer derived cell lines, suggesting that E2 interruption, observed in cancer derived cell lines, is not causally related to the high level of E7 expression and, therefore, deregulation of the P97 promoter may not be a prerequisite for HPV-16 associated cancer development.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP652023.RADB6JPT_6mBCJiCF8yPVbgcMzXYWt4T4jB5D8PyQ0nmY130_provenance.
- NP652023.RADB6JPT_6mBCJiCF8yPVbgcMzXYWt4T4jB5D8PyQ0nmY130_assertion evidence source_evidence_literature NP652023.RADB6JPT_6mBCJiCF8yPVbgcMzXYWt4T4jB5D8PyQ0nmY130_provenance.
- NP652023.RADB6JPT_6mBCJiCF8yPVbgcMzXYWt4T4jB5D8PyQ0nmY130_assertion SIO_000772 1651587 NP652023.RADB6JPT_6mBCJiCF8yPVbgcMzXYWt4T4jB5D8PyQ0nmY130_provenance.
- NP652023.RADB6JPT_6mBCJiCF8yPVbgcMzXYWt4T4jB5D8PyQ0nmY130_assertion wasDerivedFrom befree-20150227 NP652023.RADB6JPT_6mBCJiCF8yPVbgcMzXYWt4T4jB5D8PyQ0nmY130_provenance.
- NP652023.RADB6JPT_6mBCJiCF8yPVbgcMzXYWt4T4jB5D8PyQ0nmY130_assertion wasGeneratedBy ECO_0000203 NP652023.RADB6JPT_6mBCJiCF8yPVbgcMzXYWt4T4jB5D8PyQ0nmY130_provenance.